TRC102
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for TRC102, covering 2010-09-10 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer [Phase 2]